Phase 1 / 2 Study of SAR439859 Single Agent and in Combination With Palbociclib in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Breast Cancer
Age: Between 18 - 80 Years
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required